New Horizon Health (HKSE:06606) EPS (Diluted) : HK$0.24 (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health EPS (Diluted)?

New Horizon Health's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was HK$0.28. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.24.

New Horizon Health's EPS (Basic) for the six months ended in Jun. 2023 was HK$0.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.24.

New Horizon Health's EPS without NRI for the six months ended in Jun. 2023 was HK$0.30. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.28.

During the past 12 months, New Horizon Health's average EPS without NRIGrowth Rate was -29.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 24.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, New Horizon Health's highest 3-Year average EPS without NRI Growth Rate was 24.50% per year. The lowest was -153.40% per year. And the median was -64.45% per year.

New Horizon Health EPS (Diluted) Historical Data

The historical data trend for New Horizon Health's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health EPS (Diluted) Chart

New Horizon Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Diluted)

-0.61

-0.41

-2.24

-9.98

-0.21

New Horizon Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EPS (Diluted)	Get a 7-Day Free Trial				-10.37	0.53	-0.18	-0.05	0.28

Competitive Comparison of New Horizon Health's EPS (Diluted)

For the Medical Devices subindustry, New Horizon Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where New Horizon Health's PE Ratio falls into.

New Horizon Health EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

New Horizon Health's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-88.486	-	0)	/	422.929
	=	-0.21

New Horizon Health's Diluted EPS for the quarter that ended in Jun. 2023 is calculated as

Diluted EPS (Q: Jun. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(137.438	-	0)	/	489.298
	=	0.28

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.24

New Horizon Health (HKSE:06606) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

New Horizon Health EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of New Horizon Health's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

Executives

Invesco Advisers, Inc.	2102 Investment manager
Chen Yiyou	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Bancasa Holding Limited	2201 Interest of corporation controlled by you
Mst Development Limited	2101 Beneficial owner
Yao Naxin	2305 Beneficiary of a trust
Janus Henderson Group Plc	2102 Investment manager
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Zhu Yeqing	2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines